COLL
Collegium Pharmaceutical IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$1.13B
P/E Ratio
16.85
EPS
$2.06
Beta
0.75
52W High
$50.79
52W Low
$29.11
50-Day MA
$34.01
200-Day MA
$39.42
Dividend Yield
—
Profit Margin
9.41%
Forward P/E
4.62
PEG Ratio
0.00
About Collegium Pharmaceutical Inc
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and markets pain management medications. The company is headquartered in Stoughton, Massachusetts.
Fundamentals
| Revenue (TTM) | $796.33M |
| Gross Profit (TTM) | $710.08M |
| EBITDA | $425.05M |
| Operating Margin | 16.00% |
| Return on Equity | 27.40% |
| Return on Assets | 7.60% |
| Revenue/Share (TTM) | $25.06 |
| Book Value | $9.64 |
| Price-to-Book | 3.56 |
| Price-to-Sales (TTM) | 1.41 |
| EV/Revenue | 1.883 |
| EV/EBITDA | 3.65 |
| Quarterly Earnings Growth (YoY) | -46.60% |
| Quarterly Revenue Growth (YoY) | 8.90% |
| Shares Outstanding | $32.43M |
| Float | $32.06M |
| % Insiders | 1.16% |
| % Institutions | 127.64% |
Historical Volatility
HV 10-Day
52.14%
HV 20-Day
38.92%
HV 30-Day
45.56%
HV 60-Day
42.72%
HV Rank
82.5%
Volatility is currently expanding
Analyst Ratings
Consensus ($54.33 target)
2
Strong Buy3
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026